Abstract
Airway inflammation and hyperresponsiveness are recognised as major characteristics of bronchial asthma. 1 Mediators released by inflammatory cells, mainly eosinophils and mast cells, have the potential to injure airway tissues, to increase bronchial hyperresponsiveness, and to induce the structural changes that lead to progressive loss of respiratory function. 1 Because of these observations, it has been suggested that, even in mild asthma, monitoring of airway inflammation and bronchial responsiveness may be useful for gauging the severity of the disease and the eYcacy of anti-inflammatory treatment. 2 Measurements of airway hyperresponsiveness to methacholine or histamine have become popular in clinical practice, epidemiology and research, even in the paediatric population. 3 However, these tests are time consuming and require levels of collaboration not always achievable in younger patients. Assessments of airway inflammation can be obtained invasively by bronchoalveolar lavage and bronchial biopsy or non-invasively by induced sputum, 4 5 but these methods are not always applicable in clinical routine, particularly in young children. Recently, the measurement of expired nitric oxide (NO) has been proposed as a non-invasive, simple, well tolerated test to assess airway inflammation in asthma. 6 7 For practical purposes it would be important to know whether airway hyperresponsiveness can be predicted by biological markers of airway inflammation and vice versa. Studies using bronchoalveolar lavage, bronchial biopsy specimens, or induced sputum failed to show convincing correlations between airway hyperresponsiveness and inflammatory cell numbers. 8 The purpose of the present study was to evaluate whether airway hyperresponsiveness to methacholine is predictable from measurement of exhaled NO levels in children with mild intermittent asthma.
Methods

SUBJECTS
Thirty two children (12 girls) of mean (SD) age 11.8 (2.3) years (range 6-15) referred to our outpatient clinic with a history of mild intermittent asthma 2 were studied. Allergic sensitisation to one or more allergens was demonstrated in all cases by a standardised skin prick test and RAST (Pharmacia Diagnostics AB, Uppsala, Sweden). 9 Eleven patients were sensitised to house dust mite only, one to pollen only, and 20 to house dust mite + other allergens (pollens, cat, moulds). All children were known to have a positive response to a methacholine inhalation challenge-that is, a decrease in forced expiratory volume in one second (FEV 1 ) equal to or greater than 20% from control after 1 mg methacholine. None of them was taking anti-asthmatic treatments other than short acting 2 agonists on an as required basis which were avoided for 12 hours before the study.
Twenty eight age and sex matched healthy children of mean (SD) age 11.6 (2.5) years, evaluated within a diVerent study performed on schoolchildren, served as a control group. They had negative reactions to the standardised skin prick test and normal IgE serum levels in serum. 9 Parents or tutors of children were informed of the scope of the study and of the procedures involved and gave their informed consent. The protocol of the study was approved by the ethics committee of the Giannina Gaslini Institute. All the recruited children completed the study protocol.
LUNG FUNCTION AND BRONCHIAL CHALLENGE
All children were able to perform forced expiratory manoeuvres. Forced vital capacity (FVC), FEV 1 , and forced expiratory flows at 25-75% of the vital capacity (FEF 25-75% ) were measured by spirometry (Med Graphics, Pulmonary Function System 1070 Series 2, Med Graphics Corporation; St Paul, Minnesota, USA). On each occasion three forced expiratory manoeuvres were obtained and the best values were retained. All children had baseline FEV 1 of >80% predicted. 10 Aerosols of methacholine were delivered by a dosimeter device (MEFAR, Brescia, Italy) using the same ampoule for each patient. 11 Methacholine solutions were prepared on each study day in 0.9% pyrogen-free saline. The challenge was started with a methacholine dose of 0.02 mg which was then increased in doubling doses until FEV 1 , measured within one minute of methacholine inhalation, was less than 80% of the control value (inhalation of saline). The dose of methacholine causing a 20% decrease in FEV 1 (PD 20 methacholine) was calculated by interpolation of the dose-response curves.
MEASUREMENT OF EXHALED NO
A chemiluminescence analyser (Logan LR 2000 System, Kent, UK) sensitive to NO concentrations from 2 to 5000 parts per billion (ppb) by volume was used. The system was adapted for on-line measurement of NO and therefore did not require exhaled air collection, a potential source of variable loss of reactive NO. 12 Certified NO mixtures (100 ppb) in nitrogen (BOC Gases, Guildford, UK) were used for daily calibration. Environmental NO was measured before and after each study and never exceeded 15 ppb. After flushing the analyser with NO-free compressed air, subjects were asked to perform a slow expiratory vital capacity manoeuvre over 15-20 seconds through a wide bore Teflon tube 12 against a positive pressure of 6-8 cm H 2 O. During the manoeuvre oropharyngeal pressure increases suYciently to cause closure of the soft palate, thereby minimising nasal NO contamination. 12 Expiratory flow was maintained at 150-200 ml/s with the aid of visual feedback. The mean flow rate was 157 ml/s. The concentration of NO in exhaled air was recorded continuously at a rate of 250 ml/min and compared with the signal generated by the calibration mixture.
Typically, the NO concentration peaks early during expiration, probably because of the contribution of nasal NO. 12 This peak is followed by a plateau which is believed to represent NO from the lower respiratory tract. 12 Mean plateau values were calculated for each exhalation. The highest value from three successive reproducible recordings obtained at two minute intervals was retained for statistical analysis. All measurements were made by two independent observers who were unaware of the patient's health status. Exhaled NO levels Exhaled NO levels at baseline (ppb)
Figure 1 Relationship between nitric oxide (NO) levels in orally exhaled air and (A) FVC, (B) FEV 1 , (C) FEF 25-75% at baseline or (D) airway hyperresponsivenss to methacholine (PD 20 methacholine
Exhaled nitric oxide and airway hyperresponsivenesswere measured at baseline and five minutes after the end of the methacholine challenge.
The repeatability of NO measurements in orally exhaled air was evaluated according to the method of Bland and Altman. 13 For this purpose, two measurements taken on the same day in 10 children were compared. The mean diVerence in NO measurements of air exhaled from the lungs between the two measurements was 0.38 (0.4) ppb (NS). The coeYcient of repeatability was 2.2 ppb.
STATISTICAL ANALYSIS
Age, baseline lung function, and NO levels are presented as mean (SD). PD 20 methacholine values were log transformed before statistical analysis and are presented as geometric means. The Student's unpaired or paired t tests were used when appropriate. Correlations were analysed by Spearman's rank or Pearson's correlation coeYcient. The level of statistical significance was set at p<0.05.
Results
Baseline FVC, FEV 1 , and FEF 25-75% did not differ significantly between the asthmatic and healthy children (table 1). Exhaled NO was detected in all subjects and was significantly higher in the asthmatic children than in the control group (30.0 (19.2) ppb versus 4.1 (2.6) ppb; p = 0.0001). Of the 32 asthmatic children, 30 had NO levels above 8.8 ppb (more than 2 SD above the mean of healthy controls).
In the asthma group baseline lung function or airway responsiveness to methacholine did not diVer between those children sensitised to one and those sensitised to more than one allergen. No significant correlations were found in these subjects between baseline exhaled NO levels and lung function parameters (FVC, FEV 1 , FEF 25-75% ) or PD 20 methacholine (p>0.09 for each correlation; fig 1) . Exhaled NO levels were slightly less after methacholine challenge than before (25.0 (18.0) ppb versus 30.0 (19.2) ppb; p<0.05; fig 2) .
Discussion
The results of this study show that, in children with mild intermittent asthma, exhaled NO levels are increased compared with healthy controls. However, this increase is independent of the degree of impairment of pulmonary function and of airway hyperresponsiveness.
There is convincing evidence that airway inflammation may be present even in patients with mild intermittent asthma, suggesting that an ongoing recruitment and activation of inflammatory cells may also be present in asymptomatic asthmatic subjects. 11 14 15 Although it is not known whether this "subclinical" inflammation may lead to irreversible airway remodelling, it seems reasonable to evaluate the presence of airway inflammation in asymptomatic patients in order to identify individuals (children and/or adults) who may need a closer follow up and, possibly, antiinflammatory treatment. 2 The observation that NO levels are increased in the airways of asthmatic subjects has excited considerable interest. [16] [17] [18] Indeed, several reports have suggested that measurement of this highly reactive molecule in orally exhaled air may provide a simple non-invasive method of measuring airway inflammation. 6 7 19 20 Even though the relative contribution of the diVerent cellular sources of NO is unknown, a number of observations have suggested that, in asthma, NO originates mainly from the inducible form of nitric oxide synthases (iNOS or type II NOS). 21 This enzyme is induced by proinflammatory cytokines in various cells including macrophages and airway epithelial cells. 21 Similarly, the pathways linking the inflammatory events that characterise asthma with NO production in the airways are not known, but the observation that corticosteroids reduce both exhaled NO and bronchial hyperreactivity 22 has suggested that these two characteristics of bronchial asthma may share some common mechanisms.
A causal relationship between airway inflammation and hyperresponsiveness in allergic asthma has been suggested by a number of studies based mainly on the observation that acute exposure to allergens causes enhanced airway responsiveness and inflammatory cell recruitment in the airways. 14 15 23 24 This concept, however, is challenged by three observations: (1) morphological and functional studies have shown that airway hyperresponsiveness may be sustained by airway remodelling 25 and by the inability to dilate constricted airways 26 ; (2) treatment with inhaled corticosteroids does not result in a consistent reduction of airway hyperresponsiveness and airway inflammation 27 ; and (3) recent studies have shown frequent dissociation between the numbers of inflammatory cells in the airways and airway hyperresponsiveness in allergic asthma. 8 28 29 Our study in steroid-naive asthmatic children also failed to show any significant correlation between airway inflammation, as inferred from exhaled NO levels, and bronchial responsiveness to methacholine measured as PD 20 methacholine. A similar lack of correlation was 30 31 and steroid-treated adults with unstable asthma. 32 In contrast, Dupont et al, in a similar group of steroid-naive adult patients, found highly significant correlations between NO levels in orally exhaled air and bronchial hyperresponsiveness (PD 20 methacholine) to histamine. 33 Whether these diVerent results are related to patient characteristics or to diVerent mechanisms of action of the two agents used (methacholine and histamine) is unknown. 30 34 The main statistical issue in this paper is whether there is suYcient power to detect possible relationships between exhaled NO and lung function parameters or bronchial hyperreactivity. However, the observation that the highest correlation reported (between baseline FVC and exhaled NO levels; r = 0.304, p = 0.09) has a direction (as do all the other relationships) contrary to the implied hypothesis makes the issue of insuYcient statistical power unlikely.
After methacholine the levels of exhaled NO were slightly, but significantly, less than at baseline. A similar result was reported by de Gouw et al in steroid-naive adults with mild to moderate persistent asthma 35 and also by Garnier et al 36 in five of seven subjects investigated. The mechanism underlying the reduction in exhaled NO levels during acutely induced bronchoconstriction is not completely understood, although a back diVusion of NO into the capillary bed at the bronchiolar level could play a role. This could be the result of rapid binding of NO with haemoglobin. 37 38 The hypothesis that decreases in NO after methacholine challenge could be related to reduced airway calibre is not supported by the observation here reported that the decrease in exhaled NO levels did not correlate with changes in lung function parameters.
In conclusion, the results of this study indicate that exhaled NO levels do not seem to be accurate predictors of the degree of airway responsiveness to inhaled methacholine in children with mild intermittent asthma, and confirm the hypothesis that airway inflammation may not be strictly related to bronchial hyperreactivity. 8 25 28 29 This is in line with the current understanding that airway hyperresponsiveness is the result of complex inflammatory and non-inflammatory mechanisms and that biological markers cannot be a surrogate of direct measurements of functional responses to bronchoconstrictor stimuli. 39 Other factors, such as autonomic dysfunction, recent subclinical viral infections, and early changes causing airway remodelling may all be important determinants of the inter-individual variability of airway responsiveness to methacholine in childhood asthma. 25 28 39 The clinical implications of these results are that single measurements of exhaled NO cannot provide information on airway responsiveness in children with mild intermittent asthma. Further studies are required to establish the relative clinical relevance of exhaled NO, of bronchial hyperreactivity to methacholine or to histamine, and of methacholine or histamine induced bronchoconstriction as indices of disease severity. 
